Cinarzin Plus

Indications of Cinarzin Plus

Cerebral circulatory disorders:

• Dizziness, ear buzzing (tinnitus), vascular headache, unsociability and irritability, fatigue, sleep rhythm disorders such as premature awakening, involutional depressions, loss of memory and lack of concentration, incontinence, and other aging-related disorders are among the symptoms of cerebral vascular spasms and arteriosclerosis.
• Consequences of cranial and brain trauma.
• Postapoplectic disorders are a kind of post-apoplectic syndrome.
• Migraine.

Symptoms of vascular spasms and arteriosclerosis (obliterating arteritis, thromboangitis obliterans, Raynaud's disease, diabetes, acrocyanosis pernio, etc.) such as intermittent claudication, trophic disturbances, pregangrene, trophic and varicose ulcers, paraesthesia, nocturnal cramps, cold extremities are treated with prophylaxis.

Balance problems include:

• Symptoms of labyrinthine arteriosclerosis, vestibular irritability, and Meniere's syndrome, including vertigo, dizziness, giddiness, syncopal episodes, tinnitus, nystagmus, nausea, and vomiting, are treated with prophylaxis and maintenance therapy.
• Motion sickness prevention.

 

Pharmaceutical Name

Ibn Sina Pharmaceuticals Ltd.

 

Pharmacology

Cinnarizine and Dimenhydrinate are the two active components in this product. The two drugs are from two separate drug classes. Cinnarizine belongs to a class of drugs known as calcium antagonists. Dimenhydrinate belongs to the antihistamine class of drugs. Both medications function by lowering vertigo (a feeling of spinning or dizziness) and nausea symptoms (feeling sick). Individual chemicals are less effective than the whole product.

 

Dosage & Administration

Adults: Take one tablet three times a day, after meals. Children and their parents

Adolescents under the age of 18: This is not advised.

Dosage for the elderly is the same as for adults.

 

Interaction of Cinarzin Plus

Alcohol, CNS depressants, and tricyclic antidepressants may increase the sedative effects of these medicines, as well as Cinnarizine and Dimenhydrinate. As a result, it's best to stay away from these medications while taking Cinnarizine and Dimenhydrinate.

 

Contraindications

Patients with significant hepatic impairment should avoid using Cinnarizine and Dimenhydrinate. Patients with known hypersensitivity to the active ingredients or any of the excipients should avoid using Cinnarizine and Dimenhydrinate. Patients with angle-closure glaucoma, seizures, suspicion of elevated intracranial pressure, alcohol misuse, or urine retention owing to urethroprostatic diseases should not take Cinnarizine or Dimenhydrinate.

 

Side Effects of Cinarzin Plus

Drowsiness, dry mouth, headaches, and stomach pain are all possible side effects. Impaired vision, allergic responses, light sensitivity, and difficulties peeing are all rare side effects. Weight gain, constipation, chest tightness, jaundice, worsening of angle-closure glaucoma, uncontrollable movements, unusual enthusiasm and restlessness, severe skin responses are all possible side effects.

 

Pregnancy & Lactation

During pregnancy and nursing, dimenhydrinate and cinnarizine should be avoided.

 

Precautions & Warnings

Although Cinnarizine and Dimenhydrinate do not dramatically lower blood pressure, they should be taken with caution in hypotensive patients. To avoid stomach discomfort, Cinnarizine and Dimenhydrinate should be used after meals. When providing Cinnarizine and Dimenhydrinate to Parkinson's disease patients, caution is advised.

 

Therapeutic Class

Anti-vertigo medications

 

Storage Conditions

Store in a cool (below 30°C) and dry place. Keep away from light and out of reach of children.

 

Generic of Cinarzin Plus

Cinnarizine + Dimenhydrinate